Catching cancer in the act

Using CRISPR technology, researchers are tracking the lineage of individual cancer cells as they proliferate and metastasize in real-time.

Eva Frederick | Whitehead Institute • mit
today ~10 min

dna genetics crispr cancer biology research cells school-of-science national-institutes-of-health-nih whitehead-institute

Why cancer cells waste so much energy

MIT study sheds light on the longstanding question of why cancer cells get their energy from fermentation.

Anne Trafton | MIT News Office • mit
Jan. 15, 2021 ~6 min

dna cancer biology research cells school-of-science national-science-foundation-nsf national-institutes-of-health-nih koch-institute

Small molecule, big potential for treating prostate cancer

MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.

Bendta Schroeder | Koch Institute • mit
Nov. 19, 2020 ~9 min

medicine cancer research drug-development school-of-engineering national-institutes-of-health-nih biological-engineering koch-institute

SMART researchers develop gelatin microcarrier for cell production

Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.

Singapore-MIT Alliance for Research and Technology • mit
Nov. 17, 2020 ~6 min

medicine cancer biology research cells school-of-engineering materials-science-and-engineering dmse biological-engineering bioengineering-and-biotechnology singapore-mit-alliance-for-research-and-technology-smart

Truncated immune system receptors may regulate cellular activity

Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.

Michaela Jarvis | MIT Media Lab • mit
Oct. 28, 2020 ~7 min

cancer covid-19 viruses research cells proteins media-lab school-of-architecture-and-planning school-of-science koch-institute

Silencing gene expression to cure complex diseases

Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.

Zach Winn | MIT News Office • mit
Oct. 26, 2020 ~9 min

health medicine genetics cancer startups biology rna alzheimers data disease research drug-development school-of-engineering innovation-and-entrepreneurship-ie alumniae biological-engineering

To make mini-organs grow faster, give them a squeeze

Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.

Jennifer Chu | MIT News Office • mit
Oct. 13, 2020 ~7 min

genetics cancer biology research cells mechanical-engineering school-of-engineering biological-engineering

Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy

MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.

Koch Institute • mit
Oct. 1, 2020 ~7 min

chemistry medicine cancer research school-of-engineering school-of-science biological-engineering koch-institute chemical-engineering

Gene-controlling mechanisms play key role in cancer progression

Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.

Anne Trafton | MIT News Office • mit
July 23, 2020 ~7 min

dna cancer biology research school-of-science national-institutes-of-health-nih koch-institute

How cancer drugs find their targets

Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.

Eva Frederick | Whitehead Institute • mit
June 26, 2020 ~10 min

medicine cancer biology research drug-development school-of-science whitehead-institute koch-institute drug-delivery

/

16